MLTX Stock Outstanding Shares
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
ShortableYes
OptionableYes
Short Percent Of Outstanding Shares11.44
Short Percent Of Float27.61
Shares Outstanding63.28M
Shares Float28.07M
Shares Short7.24M
Short Ratio21.51
27.61%
Short % of Float11.44%
Short % of Shares OutstandingMarket Insider MLTX
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
Major Holders Summary
15.47% Percentage of Shares held by All Insiders
102.78% Percentage of Shares held by All Institutions
121.6% Percentage of Float held by Institutions
178
Number of Institutions Holding SharesInstitutional Ownership
About 102.78% of MLTX shares are held by financial institutions. AVORO CAPITAL ADVISORS LLC is the top corporate investor, holding 2.58M shares valued at $129.59M. A 5.25% stake in MoonLake Immunotherapeutics is owned by the company. JEFFERIES FINANCIAL GROUP INC. owns 8.8K shares valued at $442.02K, which translates its holding of 0.02% of the stake in the company.
MLTX Insiders
Among the MLTX insiders holding of 15.47% of the stake in company, CHEN BIHUA, 10 percent owner, holds the largest shares of 8.49M. SANTOS DA SILVA JORGE, Chief Executive Officer, is the second largest MLTX insider with ownership of 2.98M shares. BVF PARTNERS L P/IL, , stands third with possession of 1.29M shares of that stake.
Buying/Selling by Insiders
Frequently Asked Questions
How many institutions own MLTX stock?
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MLTX shares is 178, representing 102.78% of the company's common stock.
Who are the major shareholders selling MoonLake Immunotherapeutics stock?
JEFFERIES FINANCIAL GROUP INC., in the last quarter, reduced its stake in MLTX by -49.43% restricting it's holding to 8.8 thousand shares of worth nearly $442.02K. ENVESTNET ASSET MANAGEMENT INC also lessened -7.4% of the MLTX shares from its portfolio, reducing its holding to 8.44 thousand shares of worth $424.04K. LPL FINANCIAL LLC also shunned MLTX shares holding by -8.53% last quarter which brought its holding to 6.65 thousand shares worth $333.83K.
Investors who are buying MLTX stock?
As per its latest 13F filing, QUBE RESEARCH & TECHNOLOGIES LTD increased its stake in MLTX by 100% in the last quarter. The institutional holder raised its holding to 11.3 thousand shares having worth more than $567.60K. TREXQUANT INVESTMENT LP also added 100% more shares of MLTX to its portfolio, raising its holding to 9.7 thousand shares of worth $487.08K. NEW YORK STATE COMMON RETIREMENT FUND also increased its MLTX shares holding by 8,983.52% which brought its holding to 8.27 thousand shares worth $415.00K.
MLTX's major insiders: who are they?
The insider with the most stakes in MLTX is Chen Bihua , 10 percent owner at the company. Additionally, MLTX stock is highly held by Chief Executive Officer Santos da Silva Jorge and BVF PARTNERS L P/IL among others.
Did an insider recently sell MLTX stock?
Company executives, directors, and other insiders own 15.47% percent of MoonLake Immunotherapeutics's stock. Within the last six months, there have been 0 transaction(s) in which MLTX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include STURGE SIMON, BVF PARTNERS L P/IL, and SANTOS DA SILVA JORGE.
Which insider recently purchased MLTX stock?
There have been 0 transaction(s) during the past 6-months in which MoonLake Immunotherapeutics insiders have bought stock, totalling 0 shares
How much of MLTX does insiders own?
Around 0 MoonLake Immunotherapeutics shares are held by insiders, which represents about 15.47% of MLTX stock.
Who is the insider with the largest stake?
MLTX 10 percent owner, Chen Bihua holds the largest portfolio of the company's shares. MLTX shares owned by Chen total nearly 8.49 million.
Which institution holds the most shares in MLTX?
AVORO CAPITAL ADVISORS LLC is the largest institutional owner in MLTX which holds 2.58 million shares worth $129.59M or 5.25% of the total MLTX shares outstanding followed by JEFFERIES FINANCIAL GROUP INC. with ownership of 8.8 thousand shares representing 0.02% of the MLTX ownership. ALLIANZ ASSET MANAGEMENT GMBH is the third largest stakeholder with 12.3 thousand shares or 0.03% of the ownership worth more than $617.83K.
Is MoonLake Immunotherapeutics stock optionable?
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MLTX is concerned, it is a stock which is optionable.
Is there a short position on MLTX's shares?
Number of MLTX shares short is 7.24M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
About how many outstanding MLTX shares are there?
As of today, 63.28M shares of MLTX are outstanding.
Is there many float in MLTX stock?
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MLTX has 28.07M shares in float.
MLTX short ratio: what is it?
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MLTX is 21.51.